product Image
DiaPlexC™ RV13 Detection Kit (Respiratory Disease)
Model Name
-
Series
Molecular Diagnostic (Pathogen Detection)
Data
-
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125214
Product Name
DiaPlexC™ RV13 Detection Kit (Respiratory Disease)
Model Name
-
Size
-
Weight
-
Product Details

DiaPlexC™ RV13 Detection Kit

OneStep Multiplex RT-PCR based assay system for simultaneous detection of 13 major respiratory viruses

CE-IVD


Viral infections are among the leading causes of respiratory disease in children. Most of these infections are caused By respiratory syncyrial virus(RSV), influenza virus A or B (Inf A or Inf B), parainfluenza virus(hPIV-I, II and III), rhinovirus (RV) or adenovirus (AdV). Several recently discovered viruses, such as human metapneumovirus (hMPV), human bocavirus (hBoV), Enterovirus(EV) and the human coronaviruses (hCoVs) 229E and OC43, have been identified as potential respiratory pathogens.





Specification


DiaPlexC™ RV13 Detection Kit
Detection targetSet I : Metapneumovirus (MPV) Coronavirus OC43(CoV OC43) Coronavirus 229E (CoV 229E) Enterovirus (EntV)
Parainfluenza - Ⅰ (PIV-Ⅱ)
Parainfluenza - Ⅱ (PIV-Ⅱ)
Parainfluenza - Ⅲ (PIV-Ⅲ)
Set II : Respiratory syncytial virus (RSV A & B)
Adenovirus (AdV)
Bocavirus (BoV)
Rhinovirus (RV A/B/C)
Influenza Virus A (Inf A)
Influenza Virus B (Inf B)

RegistrationCE-IVD
Detection technologyConventional (End-point) OneStep Multiplex RT-PCR
Specimen typeNasopharyngeal swab, Nasopharyngeal aspirate, Bronchoalveolar lavage (BAL), Nasal swab, Oropharyngeal swab, Sputum
Analytical sensitivity10 - 10² copies
Compatible instruments*ABI Veriti thermal Cycler (Applied Biosystems) recommended
PCR running time~ 3 hrs




Features

- Simple & Rapid detection system : OneStep Multiplex qRT-PCR based detection

- HotStart PCR system : Ultra high specific and sensitive result

- Reliable system : Automatic PCR control

- Positive control included

- CE certification





Experimental


LaneInterpretation (detection)
1MPV
2CoV 229E
3EntV
4CoV OC43
5PIV-Ⅲ
6PIV-Ⅱ
7PIV-Ⅰ
8Negative (or NTC)


LaneInterpretation (detection)
1RSV A&B
2AdV
3BoV
4RV A/B/C
5Inf A
6Inf B
7Negative (or NTC)




Citation&Papers

Fouchier RAV, Munster A, Wallenstein TM, Bestebroer S, Herfst D, Smith GF,

et al. J Virol. 2002;79:2814-2822

Lamb RA, Krug R. Field Virology,

Lippincott-Raven Philadelphia. 1996; 1353-1395.

Ha Y, Stevens, DJ,

Wiley DC. The EMBO Journal. 2002;21;865-875.

Russell RJ, Gamblin SJ, Haire LF, Stevens DJ, Xiao B, Ha Y,

et al. Virology. 2004;287-296.





Ordering information

TechnologyCat. No.ProductContents
Conventional (End-point) PCRSMD50-K020 (20 reaction)DiaPlexC ™ RV13 Detection KitOneStep RT-PCR Enzyme mix (RV13)
2X OneStep RT-PCR Buffer (RV13)
Primer Mixture Ⅰ (RV13)
Primer Mixture Ⅱ (RV13)
Standard Marker Ⅰ (RV13)
Standard Marker Ⅱ (RV13)
Control Template Ⅰ(RV13)
Control Template Ⅱ (RV13)
RNase free Water
SMD50-K100 (100 reaction)





More products
SOLGENT
DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry